{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:20:16Z","timestamp":1758050416924,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bulcan.2020.10.018","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T11:39:56Z","timestamp":1610105996000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases"],"prefix":"10.1016","volume":"108","author":[{"given":"Sonia","family":"Ben Nasr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aref","family":"Zribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Ben Hassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosr","family":"Doghri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichrak","family":"Ben Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Trigui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Fendri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihen","family":"Ayari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Balti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrazek","family":"Haddaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2020.10.018_bib0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s40064-016-2351-x","article-title":"Toxicities of docetaxel: original drug versus generics-a comparative study about 81 cases","volume":"5","author":"Elm\u2019hadi","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0115","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/annonc\/mdv129","article-title":"The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)","volume":"26","author":"Al-Batran","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.018_bib0120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2015.10.010","article-title":"Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: a systematic review","volume":"41","author":"Frederiks","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.018_bib0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0973-1482.92004","article-title":"Toxicities, dose reduction and delay of docetaxel and paclitaxel chemotherapy in breast cancer without distant metastases","volume":"7","author":"Woo","year":"2011","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2008.01.008","article-title":"Peripheral nerve damage associated with administration of taxanes in patients with cancer","volume":"66","author":"Argyriou","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0135","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2005.04.0543","article-title":"Peripheral neuropathy induced by microtubule stabilizing agents","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0140","first-page":"1191","article-title":"Nail changes due to docetaxel- a neglected side effect and nuisance for the patient","volume":"15","author":"Winther","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0145","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jjco\/hym042","article-title":"Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer","volume":"37","author":"Hong","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0150","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/cncr.23333","article-title":"Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot","volume":"112","author":"Scotte","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2020.10.018_bib0155","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/sj.bjc.6601496","article-title":"The taxanes: toxicity and quality of life considerations in advanced ovarian cancer","volume":"89","author":"Guastalla","year":"2003","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.018_bib0160","first-page":"2679","article-title":"Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review","volume":"21","author":"Poi","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2407-11-131","article-title":"Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients short and long-term outcome in taxane and anthracycline-based chemotherapy of metastatic breast cancer a pooled analysis","volume":"11","author":"Loibl","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10147-011-0349-5","article-title":"Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials","volume":"18","author":"Ryoichi","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0175","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1158\/1078-0432.CCR-06-2345","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871","volume":"13","author":"Lewis","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cas.12647","article-title":"Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose","volume":"106","author":"Hirotsugu Kenmotsu","year":"2015","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.bulcan.2020.10.018_bib0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4048\/jbc.2015.18.4.356","article-title":"Safety Results of Docetaxel-(Taxotere\u00ae)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II","volume":"18","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0190","first-page":"2633","article-title":"Pharmacogenetic approach to toxicity in breast cancer patients treated with taxanes","volume":"37","author":"Angelini","year":"2017","journal-title":"Anti Can Res"},{"issue":"6","key":"10.1016\/j.bulcan.2020.10.018_bib0195","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.bulcan.2020.10.018_bib0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/157015906776359568","article-title":"Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives","volume":"4","author":"Scripture","year":"2006","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.bulcan.2020.10.018_bib0205","first-page":"901","article-title":"Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment","volume":"14","author":"Schwenkglenks","year":"2006","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2020.10.018_bib0210","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.21873\/anticanres.12927","article-title":"Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients","volume":"38","author":"Grabowski","year":"2018","journal-title":"Anticancer Res"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:40Z","timestamp":1757792020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120304951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0007455120304951"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.10.018","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}